Status:
COMPLETED
A Cross-Cultural Assessment of the Motivations of Healthy Participants in Phase I Research
Lead Sponsor:
National Institutes of Health Clinical Center (CC)
Conditions:
Healthy Volunteer
Eligibility:
All Genders
18+ years
Brief Summary
Background: * Individuals often participate in clinical trials to seek new therapies and free medical treatments for their illnesses or chronic conditions. However, less is known about the motivation...
Detailed Description
This healthy volunteer motivation study is a sub-study of Phase I drug development studies conducted by Pfizer International. The substudy is designed to evaluate the primary and secondary motivations...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Participants will be willing adults who have participated in an informed consent session for a designated Phase I study at a Pfizer CRU. Participants in New Haven and Singapore must be able to read and answer question in English and participants in Brussels must be able to read and answer questions either in English, French, or Flemish. Only adults (over 18 years old) who can provide their own consent will be included.
- EXCLUSION CRITERIA:
- Participants in Pfizer phase I studies who are unable or unwilling to complete the survey instruments.
Exclusion
Key Trial Info
Start Date :
February 19 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 8 2018
Estimated Enrollment :
1278 Patients enrolled
Trial Details
Trial ID
NCT01485250
Start Date
February 19 2010
End Date
August 8 2018
Last Update
December 17 2019
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892
2
Pfizer CRU
Brussels, Belgium
3
Pfizer CRU
Singapore, Singapore